• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Apitope - Articles and news items


Enrolment completes for Phase IIa trial of ATX-MS-1467

Industry news / 6 August 2015 / Victoria White

Apitope today announced that its partner, Merck Serono, has completed patient enrolment for the Phase IIa study of ATX-MS-1467 (also known as M2736)…


Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +